SectorChemical and pharmaceutical
Established Date--
Listing Date05/04/2024
ExchangeNASDAQ Stock Exchange
Full-time Employees51
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3565 General Atomics Court, Suite 200, San Diego, California 92121
BusinessDevelops therapies for neurological and immunology indications.
IntroductionContineum Therapeutics, Inc., was incorporated in Delaware in 2009 as Versense Pharmaceuticals, Inc., and adopted its current name in November 2023 after several mergers and name changes. The Company is a clinical-stage biopharmaceutical company focused on the development of differentiated oral small molecule therapies for neuroinflammatory and immunological indications with significant unmet needs. Its product line includes the wholly-owned drug candidate PIPE-791 for idiopathic pulmonary fibrosis and chronic pain, and the co-developed drug candidate PIPE-307 for depression and multiple sclerosis.